Quick Takeaways
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G/A for Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share (DNTH).
- Disclosed ownership: 9.4%.
- Date of event: 31 Dec 2024.
RA CAPITAL MANAGEMENT, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share (DNTH)
- Filing Manager
- RA CAPITAL MANAGEMENT, L.P.
- Reporting Manager
- RA Capital Management, L.P.
- Symbol
- DNTH
- Shares outstanding
- 30,497,160 shares
- Disclosed Ownership
- 2,866,733 shares
- Ownership
- 9.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 18:32:42 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RA CAPITAL MANAGEMENT, L.P. disclosed 9.4% ownership in Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share (DNTH) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 18:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 9.4% | 2,866,733 | 0 | 2,866,733 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | |
| Peter Kolchinsky | 9.4% | 2,866,733 | 0 | 2,866,733 | /s/ Peter Kolchinsky | Peter Kolchinsky | |
| Rajeev Shah | 9.4% | 2,866,733 | 0 | 2,866,733 | /s/ Rajeev Shah | Rajeev Shah | |
| RA Capital Healthcare Fund, L.P. | 9.4% | 2,866,733 | 0 | 2,866,733 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager |